These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23301896)

  • 1. Ginseng in the treatment of fatigue in multiple sclerosis: a randomized, placebo-controlled, double-blind pilot study.
    Etemadifar M; Sayahi F; Abtahi SH; Shemshaki H; Dorooshi GA; Goodarzi M; Akbari M; Fereidan-Esfahani M
    Int J Neurosci; 2013 Jul; 123(7):480-6. PubMed ID: 23301896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American ginseng does not improve fatigue in multiple sclerosis: a single center randomized double-blind placebo-controlled crossover pilot study.
    Kim E; Cameron M; Lovera J; Schaben L; Bourdette D; Whitham R
    Mult Scler; 2011 Dec; 17(12):1523-6. PubMed ID: 21803872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis.
    Breuer B; Pappagallo M; Knotkova H; Guleyupoglu N; Wallenstein S; Portenoy RK
    Clin Ther; 2007 Sep; 29(9):2022-30. PubMed ID: 18035201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.
    Stankoff B; Waubant E; Confavreux C; Edan G; Debouverie M; Rumbach L; Moreau T; Pelletier J; Lubetzki C; Clanet M;
    Neurology; 2005 Apr; 64(7):1139-43. PubMed ID: 15824337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.
    Tomassini V; Pozzilli C; Onesti E; Pasqualetti P; Marinelli F; Pisani A; Fieschi C
    J Neurol Sci; 2004 Mar; 218(1-2):103-8. PubMed ID: 14759641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double-blind, placebo controlled trial.
    Lappin MS; Lawrie FW; Richards TL; Kramer ED
    Altern Ther Health Med; 2003; 9(4):38-48. PubMed ID: 12868251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the effects of amantadin, modafinil and acetyl-L-carnitine on fatigue in multiple sclerosis--result of a pilot randomized, blind study.
    Ledinek AH; Sajko MC; Rot U
    Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S86-9. PubMed ID: 24321164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of armodafinil on cognition in multiple sclerosis: a randomized, double-blind crossover pilot study.
    Bruce J; Hancock L; Roberg B; Brown A; Henkelman E; Lynch S
    Cogn Behav Neurol; 2012 Sep; 25(3):107-14. PubMed ID: 22960434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized placebo-controlled cross-over study using a low frequency magnetic field in the treatment of fatigue in multiple sclerosis.
    de Carvalho ML; Motta R; Konrad G; Battaglia MA; Brichetto G
    Mult Scler; 2012 Jan; 18(1):82-9. PubMed ID: 21788248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of Chinese herbal medicines for the treatment of symptomatic hepatitis C.
    Jakkula M; Boucher TA; Beyendorff U; Conn SM; Johnson JE; Nolan CJ; Peine CJ; Albrecht JH
    Arch Intern Med; 2004 Jun; 164(12):1341-6. PubMed ID: 15226169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of memantine for multiple sclerosis-related fatigue: A pilot randomized, double-blind placebo-controlled trial.
    Falsafi Z; Tafakhori A; Agah E; Mojarrad M; Dehghani R; Ghaffarpour M; Aghamollaii V; Mousavi SV; Fouladi Z; Pourghaz B; Balali P; Harirchian MH
    J Neurol Sci; 2020 Jul; 414():116844. PubMed ID: 32335343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis.
    Möller F; Poettgen J; Broemel F; Neuhaus A; Daumer M; Heesen C
    Mult Scler; 2011 Aug; 17(8):1002-9. PubMed ID: 21561959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of Ginkgo biloba on functional measures in multiple sclerosis: a pilot randomized controlled trial.
    Johnson SK; Diamond BJ; Rausch S; Kaufman M; Shiflett SC; Graves L
    Explore (NY); 2006 Jan; 2(1):19-24. PubMed ID: 16781604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of Bio-Electromagnetic-Energy Regulation therapy on fatigue in patients with multiple sclerosis.
    Haase R; Piatkowski J; Ziemssen T
    Altern Ther Health Med; 2011; 17(6):22-8. PubMed ID: 22314716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis.
    Cree BA; Kornyeyeva E; Goodin DS
    Ann Neurol; 2010 Aug; 68(2):145-50. PubMed ID: 20695007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis.
    Wingerchuk DM; Benarroch EE; O'Brien PC; Keegan BM; Lucchinetti CF; Noseworthy JH; Weinshenker BG; Rodriguez M
    Neurology; 2005 Apr; 64(7):1267-9. PubMed ID: 15824361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sun ginseng on subjective quality of life in cancer patients: a double-blind, placebo-controlled pilot trial.
    Kim JH; Park CY; Lee SJ
    J Clin Pharm Ther; 2006 Aug; 31(4):331-4. PubMed ID: 16882101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study.
    Achiron A; Givon U; Magalashvili D; Dolev M; Liraz Zaltzman S; Kalron A; Stern Y; Mazor Z; Ladkani D; Barak Y
    Mult Scler; 2015 May; 21(6):767-75. PubMed ID: 25344375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of BEMER magnetic field therapy on the level of fatigue in patients with multiple sclerosis: a randomized, double-blind controlled trial.
    Piatkowski J; Kern S; Ziemssen T
    J Altern Complement Med; 2009 May; 15(5):507-11. PubMed ID: 19422286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing fatigue in multiple sclerosis: Dutch modified fatigue impact scale.
    Kos D; Kerckhofs E; Nagels G; D'Hooghe BD; Duquet W; Duportail M; Ketelaer P
    Acta Neurol Belg; 2003 Dec; 103(4):185-91. PubMed ID: 15008502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.